The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of…

Hepatocellular Carcinoma Recurrent

~Estimated

~$10 – $7,500

Barbara Ann Karmanos Cancer InstituteNCT07118202

Phase 1

A Phase 1/ 2a, Multicenter Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

This Phase 1/ 2a study is a multicenter study to evaluate the safety, tolerability and efficacy of SCG101 in subjects with hepatitis B virus-related hepatocell…

Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent

~Estimated

~$10 – $8,750

SCG Cell Therapy Pte. Ltd.NCT05417932